enteric fever(dr. b. erghan)-r.ppt

Upload: profarmah6150

Post on 14-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    1/36

    Enteric fever

    Eghan BA

    24/2/2005

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    2/36

    Salmonella infections

    Genus: Salmonella

    Named after : Pathologist, Salmon

    Family: enterobacteriacae

    2300 serotypes

    Grouped: O antigen (somatic)

    Further serotyed:Flagella (H) and surface virulence(Vi) antigen

    Most of which originating in animals eg poultry andtransmitted to man either directly or in food

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    3/36

    Based on DNA studies, all salmonellae are

    now considered a single species (Scholeraesuis),

    separated into 7 distinct subgroups.

    By convention, these subgroups are often

    referred to as separate species (eg, S typhiinstead ofS choleraesuis subgroup typhi)

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    4/36

    Mode of transmission

    Ingestion of food derived from infected

    animals contaminated with faeces of infectedindividual

    Raw milk and raw milk products

    Undercooked or raw eggs and egg products

    Meat and meat products Contaminated water

    Shellfish from water polluted by raw sewage.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    5/36

    The bacteria must survive the pH in stomach

    and colonize the small intestines. Attach and penetrate the intestinal mucosa

    resulting in diarrhoea from direct mucosal

    damage or by action of bacterial toxins.

    Also invasion of the lymphoid tissue withinthe GI tract and multiplication within

    macrophages leading to bacteraemia

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    6/36

    Factors predisposing an individual to

    infection include

    Studies suggest that infection may be inoculum-dependent. In healthyindividuals previously,ingestion of

    105 organisms: clinical disease in 25% of volunteers

    10

    7

    organisms: caused disease in 50% of volunteers 109 organisms caused disease in 95% of volunteers.

    As the number of organisms increased, the incubation period decreased.

    A gastric pH of less than 1.5 kills most salmonellae. Patients who continually ingest antacids

    have had a gastrectomy

    have achlorhydria due to aging

    or other factors eg. Inflammatory bowel disease, malignancy

    require lower numbers of organisms to produce clinical disease.

    Possession of Vi antigen by S typhiis linked with increased pathogenicity.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    7/36

    Syndromes of Salmonella infections

    Gastroenteritis ( the most frequent manifestation)

    Typhoid and paratyphoid fever (enteric fever)

    Enterocolitis

    Septicaemia

    Metastastic lesions (complicating septicaemia) Osteomyelitis, septic arthritis, liver abscess, brain abscess

    meningitis, pneumonia, endocarditis, arteritis, septicarthritis, splenic and hepatic abscesses, and soft tissueabscesses.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    8/36

    Gastroenteritis

    Incubation period; 8-48 hours

    Presentation:

    Nausea, vomiting progressing to abdominal cramping and

    diarrhoea which may be bloody

    Physical findings:

    Fever > 38C

    Abdominal tenderness or signs consistent to peritonitis

    Gross or occult blood may be found on rectal examination.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    9/36

    Typhoid fever or enteric fever

    History

    Incubation period: varies with the size of the infecting dose.

    a median dose of one million to one billion organismsnecessary to produce symptoms

    Typhoid fever: averages 10-20 (range 3-56) days.

    In paratyphoid fever: 1-10 days.

    The duration of illness in an untreated individual is usually four

    weeks. In the incubation period, 10-20% of patients have transient

    diarrhea.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    10/36

    As bacteremia develops, Fever; 39-40C (Rising remittent fever as high as (39-40C.

    Step-wise fashion over 2-3 days.) headaches.

    malaise,.

    Constipation

    anorexia

    myalgia,

    cough,

    sore throat

    After 1 week if untreated patients condition worsen leadingmental confusion

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    11/36

    Physical findings

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    12/36

    First week

    Rose spots: Crops of 2-4 mm diameter pink

    papules which fades with pressure developon the upper abdomen and lower chest

    between the 7th and 12th days. Caused by

    bacterial embolization, and culture results of

    skin snips of the spots may be positive. Relative bradycardia

    Dicrotic pulse are also common at this time.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    13/36

    Second week

    Toxic appearance

    Apathetic Fever sustained.

    Abdomen distention

    Splenomegaly

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    14/36

    Third week

    Toxicity increases

    Weight loss Fever persists

    Delirious state (typhoid state or typhoidpsychosis ) emerges.

    Pronounced abdominal distension liquid, foul, green-yellow diarrhea (pea soup

    diarrhea).

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    15/36

    Third week (contd)

    Patient is weak

    thready pulse

    Tachypnoic

    Crackles may develop over the lung bases.

    Death may occur at this stage from overwhelming

    Toxemia. Myocarditis.

    Intestinal hemorrhage.

    Perforation.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    16/36

    Fourth week

    In patients surviving into the fourth week, the

    fever, mental state, and abdominaldistension slowly improve over a few days,

    but intestinal complications may still occur.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    17/36

    Differentials

    Abdominal abscess

    Amoebic hepatic abscess

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    18/36

    Investigation

    Complete blood count moderate anemia

    Raised ESR

    Thrombocytopenia relative lymphopenia

    WBC increases with perforation

    Sometimes a slightly raised prothrombin time (PT) and activated partialthromboplastin time, decreased fibrinogen levels, and circulating fibrindegradation products.

    Liver Transaminases: Raised (2X or more) Raised serum bilirubin.

    Electrolytes hyponatraemia

    hypokalaemia.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    19/36

    Clinical diagnosis is suggested by:

    assays that identify Salmonella antibodies, antigens, or DNA

    But definitive diagnosis of typhoid fever requires isolation of theorganism from blood or bone marrow

    the most sensitive method of isolating S typhi and paratyphiisobtaining a bone marrow aspirate (BMA) culture.

    S typhican be isolated from BMA even if patients have been takingantibiotics for several days

    regardless of how long they have been ill. This test may be indicated in patients whose initial blood

    culture results are negative, presumably because of priorantibiotic therapy.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    20/36

    If BMA cannot be performed,

    blood, intestinal secretions, and stool culture findings are usually positive in approximately 85-90% of patients

    with typhoid fever during the first week, declining to 20-30%later in the course of the disease.

    A sensitivity of 63% has also been reported from culturingskin snips of rose spots.

    A single rectal swab: sensitivity 30-40%.

    S typhihas been isolated from the cerebrospinalfluid, peritoneal fluid, mesenteric lymph nodes,resected intestine, pharynx, tonsils, abscess, bone,and urine.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    21/36

    Serology

    Widal test ( traditional serologic test)

    It measures agglutinating antibodies against flagellar

    (H) and somatic (O) antigens ofS typhi.

    In acute infection, O antibody appears first, rising

    progressively, later falling, and often disappearing within a

    few months.

    H antibody appears slightly later but persists longer. Rising or high O antibody titers generally indicate acute

    infection, whereas elevations of H antibody help to identify

    the type of enteric fever.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    22/36

    Numerous studies have shown that the sensitivity,

    specificity, and predictive values of this test vary

    dramatically among laboratories, rendering the test'svalue to the clinician questionable.

    Wide variation is caused by differences in patient

    population, antigens, and techniques.

    The Widal reaction is indicative of typhoid fever inonly 40-60% of patients at the time of admission.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    23/36

    New innovations

    Indirect hemagglutination, indirect fluorescent Vi

    antibody, and indirect enzyme-linked immunosorbent

    assay for immunoglobulin M (IgM) andimmunoglobulin G antibodies to S typhi

    polysaccharide are available.

    Monoclonal antibodies against S typhiflagellin

    DNA probes are also available.

    Polymerase chain reaction

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    24/36

    Treatment

    Medical Care

    Nurses and doctors:

    adequate hand washing and safe disposal of feces andurine.

    Antibiotic therapy is essential and should beginempirically if the clinical evidence is strong.

    Antimicrobials:

    shorten the course, reduce the rate of complications if begun early

    reduce the case-fatality rate.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    25/36

    Surgical Care

    Consultation with a surgeon is advised when typhoid fever is

    complicated by gastrointestinal perforation.Surgical intervention for intestinal perforation

    simple closure of a perforation

    small bowel resection for patients with multiple perforations.

    Early diagnosis is key to lower mortality.

    Cholecystectomy not always successful because of persisting hepatic infection.

    indicated for gallbladder disease but not for the purpose oferadicating the carrier state.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    26/36

    Medication

    Goal is to:

    1. eradicate the infection2. reduce morbidity

    3. prevent complications.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    27/36

    antibiotics

    Ciprofloxacin (250-500 mg bid for 7-14 d)

    Levofloxacin (Levaquin) (250-500mg bid for7days)

    Cefotaxime (2 g IV q6h )

    Ceftriaxone (Rocephin) 1-2 g IV dly or bid

    Chloramphenicol

    Amoxicillin Trimethoprim and sulfamethoxazole

    Azithromycin (Zithromax)

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    28/36

    Corticosteroids

    Reduce mortality in severely ill patients with

    depressed levels of consciousness or shock.

    Dexamethasone

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    29/36

    Further management

    Management of long-term carriers is as follows:

    Prolonged courses of amoxicillin or co-trimoxazole. Failure

    rate is high if the patient has chronic gallbladder disease.

    Ciprofloxacin (750 mg bid) and norfloxacin (400 mg bid)

    have been much more effective, with cure rates of 78% and

    83%, respectively.

    Long-term urinary carriers should be assessed for urinary

    tract abnormalities, including schistosomiasis.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    30/36

    Complications

    Intestinal manifestations

    intestinal hemorrhage perforation (3-4.6% of hospitalized patients).

    Hepatobiliary manifestations

    cholangitis, cholecystitis, or hemolysis.

    Pancreatitis

    Acute renal failure and hepatitis with

    hepatomegaly

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    31/36

    Toxic myocarditis:

    tachycardia, weak pulse and heart sounds,hypotension, and electrocardiographic

    abnormalities.

    Pericarditis

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    32/36

    Neuropsychiatric manifestations A toxic confusional state, characterized by disorientation, delirium,

    and restlessness, is characteristic of late-stage typhoid.

    Facial twitching or convulsions. paranoid psychosis or catatonia may develop during

    convalescence.

    Meningismus

    Encephalomyelitis may develop, and the underlying pathology maybe that of demyelinating leukoencephalopathy.

    Rarely transverse myelitis, polyneuropathy, or cranialmononeuropathy may develop.

    spastic paraplegia, peripheral or cranial neuritis, Guillain-Barrsyndrome, schizophrenialike illness, mania, and depression.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    33/36

    Hematologic manifestations

    Subclinical disseminated intravascular

    coagulation occurs commonly in persons

    with typhoid fever.

    Hemolytic-uremic syndrome is rare.

    Haemolysis may also be associated with

    glucose-6-phosphate dehydrogenasedeficiency.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    34/36

    Genitourinary manifestations

    Approximately 25% of patients excrete S typhiin

    their urine at some point during their illness.

    Immune complex glomerulonephritis and proteinuria

    have been reported, and IgM, C3 antigen, and S

    typhiantigen can be demonstrated in the glomerular

    capillary wall.

    Nephritic syndrome may complicate chronic S typhibacteremia associated with urinary schistosomiasis.

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    35/36

    Musculoskeletal manifestations

    Skeletal muscle - shows Zenker

    degeneration, particularly affecting the

    abdominal wall and thigh muscles.

    Polymyositis .

  • 7/27/2019 Enteric fever(Dr. B. Erghan)-R.ppt

    36/36

    CNS manifestations

    Focal intracranial infections are uncommon.

    Recently, multiple brain abscesses have been

    reported.